Brown Brothers Harriman & CO Seagen Inc. Transaction History

Brown Brothers Harriman & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $1,340 - $1,513	7 Added 1.38%	515 $109,000
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $94,689 - $126,077	-700 Reduced 57.95%	508 $70,000
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $96,257 - $133,560	700 Added 137.8%	1,208 $168,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $83,632 - $107,660	508 New	508 $89,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.